- Food and Drug Administration grants rolling review of Biologics License Application for povetacicept in IgA nephropathy; Vertex to submit first module before end of year - - Updated data from RUBY-3 ...

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced several important updates across its development program for povetacicept (pove), an investigational recombinant fusion protein ...

Following the announcement that the Food and Drug Administration (FDA) granted Breakthrough Therapy Designation (BTD) to pove for the treatment of IgAN, FDA recently granted a rolling review of the ...

Vertex Pharmaceuticals (VRTX) announced several important updates across its development program for povetacicept, an investigational recombinant fusion protein therapeutic and dual antagonist of the ...

Food and Drug Administration grants rolling review of Biologics License Application for povetacicept in IgA nephropathy; Vertex to submit first module before end of year - Second pivotal development ...

Some third graders at Thorntons Ferry Elementary School in Merrimack are in a unique student organization. They maintain indoor hydroponic gardens, which they use to grow and learn about healthy foods ...

Vertex has become the latest big pharma company to acknowledge the potential of machine learning in drug development, announcing a three-year collaboration with the UK’s Genomics plc to use human ...

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Starlink is the name of a satellite network developed by the private spaceflight company SpaceX ...